Zurcher Kantonalbank (Zurich Cantonalbank) - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$288,649
+9.3%
24,692
+25.7%
0.00%0.0%
Q2 2023$264,069
-18.9%
19,6480.0%0.00%
-50.0%
Q1 2023$325,764
+15.1%
19,648
+29.1%
0.00%0.0%
Q4 2022$283,148
+137.9%
15,223
+64.8%
0.00%
+100.0%
Q3 2022$119,000
+83.1%
9,2400.0%0.00%
Q2 2022$65,000
-52.6%
9,240
-44.1%
0.00%
-100.0%
Q1 2022$137,000
+144.6%
16,535
+99.8%
0.00%
Q4 2021$56,000
+51.4%
8,277
+19.9%
0.00%
Q3 2021$37,000
-7.5%
6,9040.0%0.00%
Q2 2021$40,000
+25.0%
6,9040.0%0.00%
Q1 2021$32,000
+39.1%
6,9040.0%0.00%
Q4 2020$23,000
+9.5%
6,9040.0%0.00%
Q3 2020$21,000
-34.4%
6,9040.0%0.00%
Q2 2020$32,000
+18.5%
6,9040.0%0.00%
Q1 2020$27,000
+3.8%
6,9040.0%0.00%
Q4 2019$26,000
-29.7%
6,9040.0%0.00%
Q3 2019$37,000
+54.2%
6,904
+9.4%
0.00%
Q2 2019$24,0006,3090.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 252,199$749,0002.35%
MANGROVE PARTNERS IM, LLC 3,031,965$9,005,0001.14%
ARMISTICE CAPITAL, LLC 10,000,000$29,700,0001.08%
GABLES CAPITAL MANAGEMENT INC. 432,864$1,286,0000.83%
Worth Venture Partners, LLC 268,682$798,0000.66%
XTX MARKETS LLC 18,749$56,0000.27%
Capital Impact Advisors, LLC 203,133$603,0000.18%
Wealthspire Advisors, LLC 337,770$1,003,0000.06%
ROYCE & ASSOCIATES LP 1,784,890$5,301,0000.06%
XML Financial, LLC 40,000$119,0000.04%
View complete list of CATALYST PHARMACEUTICALS INC shareholders